The Cannabist Company Holdings Inc. (CBSTF) Hisse Analizi
Yalnızca bilgilendirme amaçlıdır. Finansal tavsiye değildir. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
$'dan işlem gören The Cannabist Company Holdings Inc. (CBSTF), 0 değerindeki bir Healthcare şirketidir. Büyüme potansiyeli, finansal sağlık ve momentum konusunda 42/100 (ihtiyatlı) olarak derecelendirilmiştir.
Son analiz: 17 Mar 2026The Cannabist Company Holdings Inc. (CBSTF) Sağlık ve Boru Hattı Genel Bakışı
The Cannabist Company Holdings Inc. operates in the cannabis industry, cultivating, manufacturing, and distributing a variety of cannabis products. With licenses in 17 U.S. jurisdictions, the company offers flower, edibles, oils, and tablets under multiple brands, positioning itself in the competitive and evolving cannabis market.
Yatırım Tezi
The Cannabist Company Holdings Inc. presents a speculative investment opportunity within the evolving cannabis industry. The company's multi-state presence, with licenses in 17 jurisdictions, provides a foundation for growth as legalization expands. However, the company's negative P/E ratio of -0.07 and a negative profit margin of -51.2% indicate significant financial challenges. The gross margin of 29.5% suggests potential for improvement through operational efficiencies and strategic pricing. Key catalysts include potential regulatory changes and expansion into new markets. Investors should closely monitor the company's ability to achieve profitability and manage its operational costs. The company's beta of 0.75 suggests lower volatility compared to the overall market.
FMP finansallarına ve nicel analizine dayanmaktadır
Temel Önemli Noktalar
- Market capitalization of $0.01 billion indicates a small-cap company with potential for growth but also higher risk.
- Negative P/E ratio of -0.07 reflects current unprofitability, requiring careful monitoring of future earnings potential.
- Profit margin of -51.2% highlights significant operational challenges and the need for improved cost management.
- Gross margin of 29.5% suggests potential for profitability if operational efficiencies are improved.
- Licenses in 17 U.S. jurisdictions provide a substantial footprint for expansion as cannabis legalization progresses.
Rakipler & Benzerleri
Güçlü Yönler
- Licenses in 17 U.S. jurisdictions.
- Diverse product portfolio.
- Established brand names.
- Vertical integration.
Zayıflıklar
- Negative profit margin.
- High operational costs.
- Limited brand recognition compared to larger competitors.
- Dependence on regulatory changes.
Katalizörler
- Ongoing: Expansion into new markets as cannabis legalization progresses.
- Ongoing: Product innovation and diversification to meet evolving consumer preferences.
- Upcoming: Potential regulatory changes at the state or federal level.
- Ongoing: Strategic partnerships and acquisitions to expand market reach.
- Ongoing: Efforts to improve operational efficiency and reduce costs.
Riskler
- Ongoing: Intense competition from other cannabis companies.
- Ongoing: Regulatory uncertainty and changing laws.
- Potential: Fluctuations in cannabis prices.
- Potential: Negative public perception of cannabis.
- Ongoing: Limited access to capital due to the nature of the business.
Büyüme Fırsatları
- Expansion into New Markets: As cannabis legalization continues to spread across the United States and internationally, The Cannabist Company has the opportunity to expand its operations into new markets. Each new state or country that legalizes cannabis represents a potential revenue stream and growth opportunity. The timeline for this growth is dependent on the pace of legalization efforts, but the long-term trend is toward greater acceptance and accessibility. The company's existing licenses in 17 U.S. jurisdictions provide a strong foundation for further expansion.
- Product Innovation and Diversification: The Cannabist Company can drive growth by innovating and diversifying its product offerings. This includes developing new cannabis-infused products, exploring different consumption methods, and catering to specific consumer preferences. The market for cannabis-infused beverages, edibles, and wellness products is growing rapidly, presenting opportunities for the company to capture new market segments. The timeline for product development and launch is relatively short, allowing the company to quickly adapt to changing consumer demands.
- Strategic Partnerships and Acquisitions: The Cannabist Company can accelerate its growth through strategic partnerships and acquisitions. Collaborating with other companies in the cannabis industry, such as technology providers, distribution networks, or retail operators, can enhance its operational capabilities and market reach. Acquiring smaller companies with complementary products or technologies can also drive growth and expand its market share. The timeline for partnerships and acquisitions varies depending on the specific opportunities, but these strategies can provide significant growth potential in the medium to long term.
- Brand Building and Marketing: Investing in brand building and marketing is crucial for The Cannabist Company to differentiate itself from competitors and attract new customers. Developing strong brand recognition and loyalty can drive sales and increase market share. This includes creating compelling marketing campaigns, engaging with consumers through social media, and sponsoring events. The timeline for brand building is ongoing, requiring consistent effort and investment over the long term. A strong brand can command premium pricing and create a sustainable competitive advantage.
- Operational Efficiency and Cost Optimization: Improving operational efficiency and optimizing costs can significantly enhance The Cannabist Company's profitability and competitiveness. This includes streamlining its cultivation and manufacturing processes, reducing waste, and optimizing its supply chain. Implementing technology solutions, such as automation and data analytics, can also drive efficiency and reduce costs. The timeline for operational improvements is ongoing, requiring continuous monitoring and optimization. Increased efficiency can lead to higher gross margins and improved financial performance.
Fırsatlar
- Expansion into new markets as legalization progresses.
- Product innovation and diversification.
- Strategic partnerships and acquisitions.
- Increasing demand for cannabis products.
Tehditler
- Intense competition.
- Regulatory uncertainty.
- Fluctuations in cannabis prices.
- Negative public perception of cannabis.
Rekabet Avantajları
- Licenses: Holding licenses in 17 U.S. jurisdictions creates a barrier to entry.
- Brand Portfolio: A diverse portfolio of brands caters to different consumer segments.
- Vertical Integration: Controlling the cultivation, manufacturing, and distribution processes provides greater control over the supply chain and product quality.
CBSTF Hakkında
The Cannabist Company Holdings Inc., formerly known as Columbia Care Inc., was founded in 2012 and rebranded in September 2023. Headquartered in New York City, the company operates in the cannabis industry, focusing on the cultivation, manufacturing, and distribution of cannabis products and related services. The company's product offerings include flower, edibles, oils, and tablets, marketed under brand names such as Seed & Strain, Triple Seven, Hedy, gLeaf, Classix, Press, and Amber. The Cannabist Company holds licenses in 17 jurisdictions within the United States, allowing it to operate across multiple states. This multi-state presence is crucial in the fragmented legal landscape of the cannabis industry in the U.S. The company aims to cater to a broad spectrum of consumer preferences through its diverse product portfolio. By offering a range of consumption methods and product types, The Cannabist Company seeks to capture different segments of the cannabis market. The company's strategic focus includes expanding its brand presence and optimizing its operational efficiency within existing markets. The Cannabist Company navigates the complex regulatory environment of the cannabis industry to establish a strong foothold in key markets.
Ne Yaparlar
- Cultivates cannabis plants in licensed facilities.
- Manufactures a variety of cannabis products, including flower, edibles, oils, and tablets.
- Distributes cannabis products through its own retail locations and wholesale channels.
- Markets its products under various brand names, such as Seed & Strain, Triple Seven, and Hedy.
- Holds licenses to operate in 17 jurisdictions in the United States.
- Provides cannabis-related services to consumers and businesses.
İş Modeli
- Cultivation and Manufacturing: The company grows cannabis and manufactures various cannabis products.
- Retail Sales: The company sells its products directly to consumers through its own retail stores.
- Wholesale Distribution: The company distributes its products to other retailers and dispensaries.
Sektör Bağlamı
The Cannabist Company operates within the rapidly evolving cannabis industry, which is characterized by increasing legalization and market expansion. The U.S. cannabis market is projected to reach significant growth in the coming years, driven by both medical and recreational use. The competitive landscape includes both large multi-state operators and smaller regional players. Companies like CANSF (Columbia Care Cannabis Corp), CNTMF (Cresco Labs Inc.), DXBRF (Dixie Brands Inc.), ELIXF (Elixinol Wellness Limited), and GHBWF (Greenlane Holdings Inc.) represent key competitors, each vying for market share through different strategies, such as brand differentiation, geographic expansion, and product innovation. The industry faces regulatory hurdles and varying state laws, requiring companies to navigate a complex legal environment.
Kilit Müşteriler
- Adult recreational cannabis users.
- Patients with medical cannabis prescriptions.
- Wholesale clients, including other dispensaries and retailers.
Finansallar
Grafik & Bilgi
The Cannabist Company Holdings Inc. (CBSTF) hisse senedi fiyatı: Price data unavailable
Son Haberler
-
The Cannabist Company Announces Strategic Transactions and Initiates Proceedings Under the CCAA
businesswire.com · 24 Mar 2026
-
Canadian Investment Regulatory Organization Trading Halt - CBST
CNW Group · 24 Mar 2026
-
The Cannabist Company Further Extends Forbearance Agreement With Senior Noteholders
businesswire.com · 17 Mar 2026
-
Innovative Industrial Properties Resolves PharmaCann Litigation; Details Lease Agreements
MT Newswires · 16 Mar 2026
Analist Konsensüsü
Fikir Birliği Derecelendirmesi
CBSTF için Benzinga, Yahoo Finance ve Finnhub'dan toplanan Al/Tut/Sat önerileri.
Fiyat Hedefleri
CBSTF için Wall Street fiyat hedefi analizi.
MoonshotScore
Bu puan ne anlama geliyor?
MoonshotScore, CBSTF'ın büyüme potansiyelini inovasyon, pazar yıkımı, finansal sağlık ve momentum dahil olmak üzere birden fazla faktörde 0-100 ölçeğinde derecelendirir.
Son Haberler
The Cannabist Company Announces Strategic Transactions and Initiates Proceedings Under the CCAA
Canadian Investment Regulatory Organization Trading Halt - CBST
The Cannabist Company Further Extends Forbearance Agreement With Senior Noteholders
Innovative Industrial Properties Resolves PharmaCann Litigation; Details Lease Agreements
Yönetim: David J. Hart
Unknown
Information on David J. Hart's background is not available in the provided context. Without additional data, it is impossible to provide details on his career history, education, or previous roles.
Sicil: Information on David J. Hart's track record is not available in the provided context. Without additional data, it is impossible to provide details on his key achievements, strategic decisions, or company milestones under his leadership.
CBSTF OTC Piyasa Bilgileri
The OTC Other tier represents the lowest tier of the OTC market, indicating that The Cannabist Company Holdings Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB, or major exchanges like NYSE or NASDAQ. Companies in this tier often have limited operating history, may be thinly traded, and are subject to less stringent regulatory oversight. This tier is typically associated with higher risk and requires greater due diligence from investors compared to companies listed on major exchanges.
- OTC Katmanı: OTC Other
- Açıklama Durumu: Unknown
- Limited liquidity due to low trading volume.
- Less stringent regulatory oversight compared to major exchanges.
- Higher price volatility.
- Potential for limited or delayed financial reporting.
- Increased risk of fraud or manipulation.
- Verify the company's legal status and registration.
- Review available financial statements and disclosures.
- Assess the company's management team and their experience.
- Research the company's business model and competitive landscape.
- Evaluate the company's risk factors and potential liabilities.
- Monitor trading volume and price volatility.
- Consult with a financial advisor before investing.
- The company has been in operation since 2012.
- The company holds licenses in 17 U.S. jurisdictions.
- The company has a diverse product portfolio.
- The company has a physical headquarters in New York City.
CBSTF Healthcare Hisse Senedi SSS
CBSTF için değerlendirilmesi gereken temel faktörler nelerdir?
The Cannabist Company Holdings Inc. (CBSTF) şu anda yapay zeka skoru 42/100, düşük puanı gösteriyor. Temel güçlü yan: Licenses in 17 U.S. jurisdictions.. İzlenmesi gereken birincil risk: Ongoing: Intense competition from other cannabis companies.. Bu bir finansal tavsiye değildir.
CBSTF MoonshotScore'u nedir?
CBSTF şu anda MoonshotScore'da 42/100 (Derece D) alıyor, bu da düşük derecelendirme gösteriyor. Puan, 9 kantitatif KPI genelinde büyüme potansiyelini, finansal sağlığı, piyasa momentumunu ve risk faktörlerini değerlendirir. En son piyasa verileri kullanılarak günlük olarak yeniden hesaplanır. Bu puan yalnızca bilgilendirme amaçlıdır.
CBSTF verileri ne sıklıkla güncellenir?
CBSTF fiyatları ABD piyasa saatleri (hafta içi 9:30-16:00 ET) sırasında gerçek zamanlı olarak güncellenir. Temeller, üç aylık veya yıllık beyanlardan sonra yenilenir. Analist derecelendirmeleri ve yapay zeka öngörüleri günlük olarak güncellenir. Haberler, finans kaynaklarından sürekli olarak toplanır.
Analistler CBSTF hakkında ne diyor?
CBSTF için analist kapsamı, büyük araştırma şirketlerinden fikir birliği derecelendirmelerini (al, tut, sat), 12 aylık fiyat hedeflerini ve kazanç tahminlerini içerir. Temel veri noktaları: fikir birliği hedef fiyatı, kapsayan analist sayısı, son yükseltmeler veya düşürmeler ve kazanç beklentilerini aşma/aşamama geçmişi. Bu sayfadaki Analist Konsensüsü bölümüne bakın.
CBSTF'a yatırım yapmanın riskleri nelerdir?
CBSTF için risk kategorileri arasında piyasa riski, şirkete özgü risk (yönetim, rekabet), finansal risk (borç, nakit yakımı) ve makroekonomik risk (oranlar, enflasyon) yer alır. Yapay zeka analizi tarafından belirlenen önemli bir risk: Ongoing: Intense competition from other cannabis companies.. 1,0'ın üzerindeki beta, S&P 500'den daha yüksek volatiliteyi gösterir. Ayrıntılar için bu sayfadaki Risk Faktörleri bölümünü inceleyin. Tüm yatırımlar kayıp riski taşır.
CBSTF'ın P/E oranı nedir?
CBSTF için P/E (fiyat-kazanç) oranı, mevcut hisse senedi fiyatını hisse başına kazancıyla karşılaştırır. Daha yüksek bir P/E büyüme beklentilerini gösterebilirken, daha düşük bir P/E değer veya azalan kazançlar gösterebilir. Anlamlı bir bağlam için CBSTF'ın P/E'sini sektördeki emsalleriyle ve S&P 500 ortalamasıyla karşılaştırın. Mevcut değerleme metrikleri için Finansallar sekmesini kontrol edin.
CBSTF aşırı değerli mi, yoksa düşük değerli mi?
The Cannabist Company Holdings Inc. (CBSTF)'ın aşırı değerli mi yoksa düşük değerli mi olduğunu belirlemek, birden fazla metriği incelemeyi gerektirir. Kapsamlı bir görünüm için değerleme oranlarını (P/E, P/S, EV/EBITDA) sektördeki emsallerle karşılaştırın. Bu bir finansal tavsiye değildir.
CBSTF'ın temettü verimi nedir?
The Cannabist Company Holdings Inc. (CBSTF) şu anda düzenli bir temettü ödemiyor veya temettü verimi verileri mevcut değil. Büyüme odaklı şirketler genellikle temettü ödemek yerine karları yeniden yatırır. En son temettü bilgileri ve ödeme geçmişi için Finansallar sekmesini kontrol edin.
Sorumluluk reddi: Bu içerik yalnızca bilgilendirme amaçlıdır ve yatırım tavsiyesi teşkil etmez. Her zaman kendi araştırmanızı yapın ve bir finans uzmanına danışın.
Resmi Kaynaklar
Veriler yalnızca bilgilendirme amaçlı sağlanmıştır.
- Information is based on available data and may be subject to change.
- Financial data may not be fully up-to-date due to the nature of the OTC listing.